Results 21 to 30 of about 1,145,953 (258)

Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The EXPeRT Recommendations

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Primary lung carcinomas and bronchial carcinoid tumors (BC) are very rare malignancies in childhood. While typical BC and mucoepidermoid carcinomas are mostly low‐grade, localized tumors with a more favorable prognosis than in adults, necessitating avoidance of overtreatment, adenocarcinomas of the lung are often diagnosed at advanced disease ...
Michael Abele   +19 more
wiley   +1 more source

Moscow and Moscow Oblast: Commonality and Specificity of Mortality Trends and Causes of Death

open access: yesЗдоровье мегаполиса
Background. The increasing life expectancy of the population of Russia and its regions is high on the agenda. Numerous studies have investigated population losses at the national level; however, such an approach hasn’t enabled to identify region-specific
V. G. Semenova, A. E. Ivanova
doaj   +1 more source

Forensic exhumations and autopsies in Zambia, Africa

open access: yesForensic Science International: Reports, 2021
To our knowledge, this is the largest case series of forensic exhumation and autopsy cases in Africa to date. This paper fills a critical knowledge gap in Africa by profiling the cases, describing the challenges of accessing burial sites, conducting ...
Luchenga Mucheleng’anga   +3 more
doaj   +1 more source

Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background The United Kingdom relapsed Wilms tumour (UKW‐R) trial aimed to improve the historically low survival rates after relapse of Wilms tumour (WT) through a prospective national risk‐stratified protocol. The trial also evaluated efficacy and toxicity of high‐dose melphalan.
Sucheta J. Vaidya   +10 more
wiley   +1 more source

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

Description Of Maternal Characteristics And Causes Of Maternal Deaths In Serang District In 2022

open access: yesProfessional Health Journal
Introduction: Maternal mortality is still a problem globally and especially occurs in developing countries, including Indonesia. Objectives: Serang Regency has the highest number of maternal deaths in Banten Province.
Fifi Musfirowati   +2 more
doaj   +1 more source

Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy   +5 more
wiley   +1 more source

The need for a mortality database in Pakistan: now or never

open access: yesJournal of the Pakistan Medical Association
Respected editor, With a staggering figure of 241.5 million inhabitants, Pakistan is considered the fifth most populous country in the world, with a growth rate of 2.55% per annum.
Sidra Waqar Qureshi, Erum Anwar
doaj   +1 more source

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Patients with high‐risk neuroblastoma who either are refractory to induction chemotherapy or relapse following multi‐modal treatment have a dismal prognosis. Based on data from the BEACON trial, since 2021 the UK national guidelines recommend bevacizumab, irinotecan, and temozolomide (BIT) for patients with relapsed/refractory ...
Thomas J. Jackson   +20 more
wiley   +1 more source

Causes of death in a nationwide cohort of community-dwellers with Alzheimer’s disease

open access: yesBMC Geriatrics, 2020
Background Alzheimer’s disease (AD) is related to higher mortality but it is not entirely evident which causes of death explain this. The objective of this study was to assess the causes of death in a nationwide cohort of clinically verified AD cases and
Anna-Maija Tolppanen   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy